전체 프로그램

CGTBiologicstaleElvira UmyarovaPhase 1

Universal Donor Expanded TGF-beta-imprinted NK Cells (Universal Donor Expanded TGF-beta-imprinted NK Cells)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 4상태 ACTIVE

AntibodystaleRegeneronPhase 2

VV1 + Cemiplimab (VV1 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4

ADCBiologicstaleShanghai Yuansong Biotechnology…Phase 2

YSCH-01 (YSCH-01)

Recurrent Glioblastoma · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

AntibodystalePeregrine PharmaceuticalsPhase 2

bavituximab (bavituximab)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2

효능 ORR 9%임상시험 4상태 ACTIVE

ADCBiologicstaleSeagen Inc.Phase 2

denintuzumab mafodotin (denintuzumab mafodotin)

Lymphoma, B-cell; Lymphoma, Large B-Cell, Diffuse · Lymphoma, B-cell

#LymphomaB-cell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 4상태 DISCONTINUED

AntibodystaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab)

Liver Cancer; Antibody · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+3

AntibodystaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab)

Hepatic Cancer; Surgery · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+4

CGTBiologicstaleAllife Medical Science and Tech…Phase 1

pd-1 and DC-NK cells (pd-1 and DC-NK cells)

Solid Tumor · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 4상태 ACTIVE

ADCBiologicstaleRochePhase 3

polatuzumab vedotin, zanubrutinib, rituximab and lenalidomide (polatuzumab vedotin, zanubrutinib, rituximab and lenalidomide)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-GRK1-RPGR (rAAV2tYF-GRK1-RPGR)

X-Linked Retinitis Pigmentosa · X-Linked Retinitis Pigmentosa

#X-LinkedRetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+2

AntibodystaleJanssenPhase 2

daratumumab (Darzalex, 89Zr-daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2

CGTAAVBiologicstaleMeiraGTx UK II LtdPhase 2

AAV - CNGB3 (AAV - CNGB3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2

CGTAAVBiologicstaleLibella Gene TherapeuticsPhase 1

AAV-hTERT (AAV-hTERT)

Alzheimer Disease · Alzheimer Disease

#AlzheimerDisease#CGT#Phase1#세포유전치료#CAR-T+2

ADCBiologicstaleAbbVie (prior sponsor, Abbott)Phase 1

ABT-700 (ABT-700)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 0%임상시험 3상태 ACTIVE

ADCBiologicstalePfizerPhase 2

ALLR3 (ALLR3)

ACUTE LYMPHOBLASTIC LEUKEMIA · ACUTE LYMPHOBLASTIC LEUKEMIA

#ACUTELYMPHOBLASTICLEUKEMIA#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

ARV-471 + Letrozole (ARV-471 + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

ADCBiologicstaleAstraZenecaPhase 3

AZD5335 (AZD5335)

Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleAstraZenecaPLPhase 2

AZD8205 (AZD8205)

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4

AntibodystaleDeutsches Herzzentrum MuenchenApproved

Abciximab (Abciximab)

Acute Myocardial Infarction · Myocardial Infarction

#MyocardialInfarction#Antibody#Approved#항체#면역항체+3